Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids

Creator

Scheinman, Robert I.
- Affiliation: N.C. Cancer Hospital, UNC Lineberger Comprehensive Cancer Center
Cogswell, Patricia C.
- ORCID: https://orcid.org/0000-0003-1246-1360
- Affiliation: N.C. Cancer Hospital, UNC Lineberger Comprehensive Cancer Center
Lofquist, Alan K.
- Affiliation: N.C. Cancer Hospital, UNC Lineberger Comprehensive Cancer Center
Baldwin, Albert
- Affiliation: N.C. Cancer Hospital, UNC Lineberger Comprehensive Cancer Center

Abstract

Glucocorticoids are potent immunosuppressive drugs, but their mechanism is poorly understood. Nuclear factor kappa B (NF-κB), a regulator of immune system and inflammation genes, may be a target for glucocorticoid-mediated immunosuppression. The activation of NF-κB involves the targeted degradation of its cytoplasmic inhibitor, IκBα, and the translocation of NF-κB to the nucleus. Here it is shown that the synthetic glucocorticoid dexamethasone induces the transcription of the IκBα gene, which results in an increased rate of IκBα protein synthesis. Stimulation by tumor necrosis factor causes the release of NF-κB from IκBα. However, in the presence of dexamethasone this newly released NF-κB quickly reassociates with newly synthesized IκBα, thus markedly reducing the amount of NF-κB that translocates to the nucleus. This decrease in nuclear NF-κB is predicted to markedly decrease cytokine secretion and thus effectively block the activation of the immune system.

Date of publication

DOI

Identifier

Related resource URL

Resource type

Rights statement

Journal title

Journal volume

Journal issue

Page start

Page end

Language

Version

ISSN

Relations

Thumbnail	Title	Date Uploaded	Visibility	Actions
	Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids.pdf	2019-05-03	Public	Download